Delivery Order SPE2DB24D6044-SPE2DB25FLHBQ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,350.41, is for the delivery of zolmitriptan 5 mg orally disintegrating tablets. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999. The award is for the supply of zolmitriptan 5 mg tablets to support federal healthcare programs. The total ceiling value of this specific delivery order is $1,076.94, with a firm fixed-price pricing type. The contract does not have a set-aside designation and is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,465.79, is for the delivery of zolmitriptan 2.5 mg orally disintegrating tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zolmitriptan 2.5 mg tablets. The contract has a ceiling value of $1,383.12 and an ultimate completion date of March 1, 2022. The contract is a firm-fixed-price arrangement, and it was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,767.49 delivery order is for the supply of 4,565,564,913 units of the pharmaceutical drug zolmitriptan 2.5 mg oral disintegrating tablets (ODT) in packages of 6 tablets. The award has a firm fixed price and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,818.56 Firm Fixed Price Delivery Order is for the supply of 4,564,287,105 units of the pharmaceutical product Zolmitriptan 2.5 mg Tablet, with an ultimate completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $2,779.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zolmitriptan 2.5 mg Orally Disintegrating Tablets, a pharmaceutical product, with a completion date of July 20, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award, SPE2DB20D3103|SPE2DB24FP9T2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,032.27 firm fixed-price delivery order is for the supply of zolmitriptan 2.5 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2024. It is not designated as a set-aside contract....
- This is a $1,487.04 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLMITRIPTN 5MG ODT 3S, a medication used to treat migraines. The award is not associated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLHBQDelivery Order
This federal contract award is a delivery order valued at $3,089.46 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of zolmitriptan 5 mg orally disintegrating tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The contract encompasses a wide array of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen's federal contract awards demonstrate its role as a key vendor for supplying essential pharmaceutical and medical products to various government agencies, particularly the DLA and other defense-related healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/27/24 |